 
                Lv1
20 积分 2025-07-16 加入
 Glutamine as a component of nutritional and metabolic therapy for surgical patients in ICU
                                            4天前
                                            求助中
Glutamine as a component of nutritional and metabolic therapy for surgical patients in ICU
                                            4天前
                                            求助中
                                         High‐dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes without a beneficial clinical or cerebral tissue effect
                                            4天前
                                            已完结
High‐dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes without a beneficial clinical or cerebral tissue effect
                                            4天前
                                            已完结
                                         High‐dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes syndrome
                                            4天前
                                            已完结
High‐dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes syndrome
                                            4天前
                                            已完结
                                         Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy
                                            18天前
                                            已完结
Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy
                                            18天前
                                            已完结
                                         Mechanisms underlying the efficacy and limitation of dopa and tetrahydrobiopterin therapies for the deficiency of GTP cyclohydrolase 1 revealed in a novel mouse model
                                            23天前
                                            已完结
Mechanisms underlying the efficacy and limitation of dopa and tetrahydrobiopterin therapies for the deficiency of GTP cyclohydrolase 1 revealed in a novel mouse model
                                            23天前
                                            已完结
                                         Tetrahydrobiopterin
                                            1个月前
                                            已完结
Tetrahydrobiopterin
                                            1个月前
                                            已完结
                                         Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia—The VasCog-2-WSO Criteria
                                            1个月前
                                            已完结
Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia—The VasCog-2-WSO Criteria
                                            1个月前
                                            已完结
                                         Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
                                            1个月前
                                            已完结
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
                                            1个月前
                                            已完结
                                         Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
                                            1个月前
                                            已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
                                            1个月前
                                            已完结
                                         Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss
                                            2个月前
                                            已完结
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss
                                            2个月前
                                            已完结